AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar TMFBlacknGold (98.96) Submitted: 6/28/2012 11:06:42 PM : Underperform Start Price: $3.77 AVNR Score: +28.03

This came up in a screen for stocks with the highest gains in the last 4 weeks. With a fair book value of $0.44 this company is greatly overvalued. Cash is shrinking every quarter along with shareholders' equity, which stands at only $60 million as of 1Q12. Should be an easy red-thumb target.

Featured Broker Partners


Advertisement